(Q45060636)

9 December 2017

title

Reduced expression of decay-accelerating factor 1 on CD4+ T cells in murine systemic autoimmune disease (English)

1 reference

9 December 2017

David M Cauvi

1

1 reference

9 December 2017

Gabrielle Cauvi

series ordinal

2

1 reference

9 December 2017

K Michael Pollard

series ordinal

3

1 reference

9 December 2017

publication date

1 June 2007

1 reference

9 December 2017

published in

Arthritis & Rheumatology

1 reference

9 December 2017

volume

56

1 reference

9 December 2017

issue

6

1 reference

9 December 2017

page(s)

1934-1944

1 reference

Deletion of decay-accelerating factor (CD55) exacerbates autoimmune disease development in MRL/lpr mice

9 December 2017

cites work

1 reference

Costimulation requirements of induced murine systemic autoimmune disease

21 January 2018

1 reference

Constitutive expression of murine decay-accelerating factor 1 is controlled by the transcription factor Sp1.

21 January 2018

1 reference

Resistance to xenobiotic-induced autoimmunity maps to chromosome 1.

21 January 2018

1 reference

Increased susceptibility of decay-accelerating factor deficient mice to anti-glomerular basement membrane glomerulonephritis

21 January 2018

1 reference

Cutting edge: murine CD59a modulates antiviral CD4+ T cell activity in a complement-independent manner

21 January 2018

1 reference

Transgenic expression of a soluble complement inhibitor protects against renal disease and promotes survival in MRL/lpr mice

21 January 2018

1 reference

Costimulation via CD55 on human CD4+ T cells mediated by CD97

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ART.22639

1 reference

9 December 2017

1 reference